Kymera Therapeutics Inc (KYMR)

Capital Expenditure

-$1.19M

TTM · Period ending: · USD

KYMR logo

KYMR Capital Expenditure

Latest reported-$1.19M
KYMR TTM CapEx (-$9.10M → -$1.19M)
High-resolution chart · PNG

KYMR capital expenditure history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Kymera Therapeutics Inc Capital Expenditure — Trailing twelve months (TTM) (USD)
Period endingCapital Expenditure (USD)
-1,194,000
-1,416,000
-1,449,000
-2,279,000
-1,909,000
-5,903,000
-12,838,000
-23,527,000
-31,793,999
-37,872,999
-34,479,999
-23,227,999
-16,396,000
-6,363,000
-2,836,000
-2,964,000
-2,024,000
-1,915,000
-1,597,000
-2,533,000
-4,636,000
-7,865,000
-9,096,000
-7,858,000
-5,660,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.